Table 3.
Variable | Hospitalization outcomes | OR (95% CI) | p-value | AOR (95% CI) | p-value | |
---|---|---|---|---|---|---|
Discharged n (%) |
Died n (%) |
|||||
Age (years) | ||||||
≤ 24 | 11 (13.4) | 7 (18.4) | 0.34 (0.11–1.01) | 0.052 | 0.39 (0.08–1.85) | 0.236 |
25–44 | 24 (29.3) | 8 (21.1) | 0.86 (0.28–2.68) | 0.796 | 0.13 (0.02–0.60) | 0.009** |
45–59 | 24 (29.3) | 6 (15.8) | 0.45 (0.16–1.25) | 0.125 | 0.31 (0.08–1.22) | 0.093 |
≥ 60 | 23 (28) | 17 (44.7) | Ref. | Ref. | ||
Gender | ||||||
Male | 34 (41.5) | 18 (47.4) | 0.79 (0.36–1.71) | 0.559 | – | – |
Female | 48 (58.5) | 20 (52.6) | Ref. | |||
Marital status | ||||||
Single | 25 (30.5) | 13 (34.2) | 0.84 (0.37–1.91) | 0.679 | – | – |
Married | 57 (69.5) | 25 (65.8) | Ref. | |||
Admission site | ||||||
IDU ward | 68 (82.9) | 18 (47.4) | 5.4(2.29–12.73) | < 0.001** | 3.27(1.08–6.89) | 0.031** |
IDU-CCU | 14 (17.1) | 20 (52.6) | Ref. | Ref. | ||
Presence of comorbidity | ||||||
Yes | 58 (70.7) | 32 (84.2) | 0.45 (0.17–1.22) | 0.173 | 1.62 (0.31–4.94) | 0.061 |
No | 24 (29.3) | 6 (15.8) | Ref. | Ref. | ||
Vaccinated with SARS-CoV-2 vaccine | ||||||
Yes | 22 (26.8) | 6 (15.8) | 2.0 (0.72–5.31) | 0.247 | 0.20 (0.05–0.83) | 0.027** |
No | 60 (73.2) | 32 (84.2) | Ref. | Ref. | ||
LOS (days) | ||||||
Short (0–5) | 11 (13.4) | 24 (63.2) | 1.09 (0.34–3.48) | 0.879 | 0.66 (0.17–2.61) | 0.556 |
Medium (6–10) | 39 (47.6) | 8 (21.1) | 11.64 (3.77–35.91) | < 0.001** | 14.28 (3.25–62.76) | < 0.001** |
Long (> 10) | 32 (39) | 6 (15.8) | Ref | Ref |
Factors found statistically significant are indicated in bold
IDU Infectious Disease Unit, IDU-CCU Infectious Disease Unit-Critical Care Unit, cOD Crude Odds Ratio, AOR Adjusted Odds Ratio, LOS Length of Stay, **Statistically significant